Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Wockhardt Limited
WOCKPHARMACurrent price
1 249 INR
+21.01 INR (+1.71%)
Last closed
1 208.35 INR
Company
www.wockhardt.com
ISIN
INE049B01025
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
National Stock Exchange of India
Capitalization
164 628 490 712 INR
Yield for 12 month
+423.25 %
1Y
3Y
5Y
10Y
15Y
WOCKPHARMA
Wockhardt Limited, a pharmaceutical and biotech company, manufactures and markets pharmaceuticals, medicinal, and chemical products in India, the United States, the United Kingdom, Switzerland, Ireland, Mexico, Russia, and internationally. It develops various molecules primarily in the areas of infectious diseases, such as WCK 5222, WCK 4282, WCK 4873, WCK 771 and WCK 2349, and WCK 6777 molecules; and active pharmaceutical ingredients. The company's biopharmaceutical products include Glaritus, a long-acting biosimilar glargine; Wosulin, a recombinant human insulin; Wepox, an r-DNA erythropoietin; human insulin; and Biovac-B, a hepatitis B vaccine. Its pipeline also includes rapid and long-acting insulin analogues, concentrated insulins, GLP1 analogues, haemopoietins, biobetters and novel products, and delivery devices. In addition, the company provides contract manufacturing services. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India. Address: Wockhardt Towers, Mumbai, India, 400051
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
37 860.23 INRP/E ratio
–Dividend Yield
–Current Year
+28 000 531 040 INR
Last Year
+26 529 452 344 INR
Current Quarter
+7 395 422 592 INR
Last Quarter
+7 005 136 389 INR
Current Year
+7 815 730 779 INR
Last Year
+15 411 300 122 INR
Current Quarter
+2 121 555 617 INR
Last Quarter
+1 911 401 482 INR
Key Figures WOCKPHARMA
1 year
3 years
5 years
10 years
EBITDA
2 079 024 446 INR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-0.17 %
PEG Ratio
–
Return On Equity TTM
-12.89 %
Wall Street Target Price
37 860.23 INR
Revenue TTM
29 271 463 801 INR
Book Value
214.82 INR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
14.8 %
Dividend Yield
–
Gross Profit TTM
14 800 852 525 INR
Earnings per share
-23.7 INR
Diluted Eps TTM
-23.7 INR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
840.6 %
Profit Margin
-11.73 %
Dividend Analytics WOCKPHARMA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History WOCKPHARMA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
17.11.2016
Forward Annual Dividend Yield
–
Last Split Factor
3:2
Payout Ratio
–
Last Split Date
28.04.2004
Dividend Date
–
Stock Valuation WOCKPHARMA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
6.3204
Price Sales TTM
5.635
Enterprise Value EBITDA
91.5984
Price Book MRQ
4.8724
Financials WOCKPHARMA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators WOCKPHARMA
For 52 weeks
222.71 INR
1 147.64 INR
50 Day MA
1 018.31 INR
Shares Short Prior Month
–
200 Day MA
722.28 INR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart